Abstract-In biotechnology-based industrial processing, micro-organisms may be handled in large concentrations in liquid culture (fermentation). Where biotechnology is used for high value products such as Pharmaceuticals, conditions are usually controlled closely. Containment is important for safety and economic reasons, therefore release of the process organism and its products into the work environment is likely to be minimized. Nevertheless, instances can and do occur where containment is breached. Although monitoring the workplace for release of process organisms must be seen as advantageous from a worker safety point of view, no specific guidance is given to the biotechnology industry. We conducted a survey by questionnaire to find out what methods were being used to monitor for process micro-organisms or their products in biotechnology, what sampling methods were used, what use was made of acquired data, details of any standards used and any need for further information. This paper describes the questionnaire used in the survey and the results obtained. The results showed that a range of monitoring methods were being used in well-defined sampling strategies, the monitoring information being used to maintain or improve work conditions. However, a need was identified for further information on sampling methods and 'typical' levels of micro-organisms that may be anticipated in the biotechnology workplace. Published by Hsevier Science Ltd.
INTRODUCTION
Biotechnology has been described in broad terms as the use of biological processes to produce goods and services, for example pharmaceutical production, or for environmental management such as the use of biological pesticides. It has existed in its simplest form (brewing and bread making) since the start of civilization. However, the manufacture of goods by biotechnology may place workers in the industry into close contact with large quantities of live micro-organisms, which could present a hazard to their health.
The micro-organisms used in biotechnological processing are usually handled, for convenience, in large concentrations in liquid culture (fermentation). In traditional biotechnology, such as brewing, vinegar production or citric acid production, fermentation often takes place in open vessels, with an obvious possibility that personnel associated with the process might be exposed to aerosols of the process organism or its products. In modern biotechnology, the product often has high value and is usually made in a controlled, closed system because 224 B. Crook and A. N. Cottam contamination could lead to expensive loss of yield or product quality. Therefore, from an economic point of view, containment which will limit the release of the process organism and its products into the work environment is of paramount importance. Of equal importance however, is that there is a statutory requirement for containment where genetically modified process organisms (GMO) are used. There is an obligation under health and safety and environmental laws to define the risk associated with any process using GMO and to put in place the appropriate containment measures (HSE, 1992) . Furthermore, the biotechnology industry has the motivation to be well controlled, not least because of the public perception that there is a high risk attached to the large-scale use of microbiological agents. Nevertheless, instances can and do occur where containment is breached. Even with the most sophisticated containment measures, where large volumes of highly concentrated suspensions of micro-organisms are being handled, there is the potential for process organisms to be released into, and beyond, the workplace environment. This might occur through an accidental release resulting from mechanical failure, the likelihood of which can be minimized through design, or from an incidental release during normal working practices, such as when samples are taken for analysis. Table 1 summarizes what might be considered to be the critical points for potential release in biotechnology.
If process organisms or their products are released into the workplace in the earlier stages of fermentation or during downstream processing, the way in which workers become exposed may be by splash, airborne droplets or a liquid aerosol. For some stages, such as preparation of the final product, potential exposure may take the form of a dust aerosol. The concentration of cells of the process organism, or of by-product, may range from very dilute or disperse to highly concentrated. For example, where the products of fermentation are being concentrated by centrifugation or filtration, the cells of the process organism may be handled in a thick paste form. Therefore the extent to which workers may be exposed may differ at different points of the process.
Instances of occupational ill-health within the biotechnology industry have been reported. These include respiratory sensitization, mostly where the process organism was a fungus or yeast (Bennett et al., 1990) . In some cases sensitization has been attributed to exposure to the product, for example antibiotics (Davies et al., 1974) (Pepys et al., 1985; Pepys, 1992) . Ingestion or inhalation of endotoxins, which form part of the cell walls of Gram-negative bacteria, can result in a fever or 'flu-like illness (Burrell and Ye, 1990) . As strains of Gram-negative bacteria, such as E. coli, often are the process organisms for industrial fermentations, there is the potential for endotoxin-related effects (sometimes referred to as "fermenter flu") following exposure (Ekenvall et al., 1983; Palchak et al, 1988) . However, much of the reported incidence of respiratory ill health, such as sensitization to fungi, has been associated with 'low technology'; simple fermentation taking place in open fermenters where the product value is relatively small and purity of the product is a less stringent requirement, and with little control of product release into the workplace environment (Topping et al., 1985) . Control measures put into place in such a work environment have been shown to be effective in preventing any further cases of sensitization (Seaton and Wales, 1994) . Overall, despite the potential sources of exposure, the incidence of ill health from exposure to process organisms or their products in biotechnology appears to be low.
To validate control measures implemented in other industries (for example, to control workers' exposure to many process chemicals) the procedures for monitoring the workplace are well denned (HSE, 1989) . However, there are at present no standard methods for workplace monitoring by sampling bioaerosols (aerosols containing biological material), or for their analysis. Many different bioaerosol sampling methods are available commercially, some of which perform better than others depending on the material being sampled and the circumstances in which sampling is taking place (Crook and Lacey, 1989) . As a result of this, a range of sampling and analytical methods are required for monitoring purposes. No exposure standards for workplace airborne biological agents exist, partly because of the lack of standardized sampling methods, but also because of limited data on dose-response relationships for most organisms and the variability in susceptibility of humans exposed. The only exception to this, with regard to the biotechnology industry, is that there are occupational exposure standards for the subtilisin group of proteolytic enzymes. The U.K. 8-h TWA and short-term exposure limits are set at 0.00006 mg m 3 (HSE, 1994) . No specific guidance is given to the biotechnology industry for monitoring the workplace for release of process organisms, although a recent publication (Cottam and Crook, 1995) has outlined sampling methods and strategies that may be relevant to the industry.
To find out what methods were being used for monitoring in biotechnology, we conducted a survey by questionnaire. We also asked how the information acquired from monitoring was used to maintain or improve workplace conditions. We invited the biotechnology industry to identify gaps in their current knowledge on sampling, monitoring and analysis. This was to enable HSE specialists to prepare well targeted and appropriate information or guidance for the industry. This paper describes the questionnaire used in the survey and the results we obtained.
QUESTIONNAIRE
A questionnaire was designed which asked specific questions about the process being undertaken, what monitoring was being done in the workplace for process micro-organisms or their products, what sampling methods were used, the use being made of any data acquired, whether any (numerical) standards were being applied and what need there was, if any, for further information. Table 2 summarizes the content of the questionnaire. A copy of the questionnaire is available from one of the authors (B. Crook) on request. A total of 49 biotechnology companies were selected from records held by the HSE of establishments registered to work with genetically modified process organisms. All companies were likely to be using well contained systems, although they were not necessarily using genetically modified organisms (GMO) at the time the study was done. The survey included companies doing work on different scales, from laboratory-to full-scale production, but did not include companies using large fermenters for brewing. A copy of the questionnaire was posted to each company, in most cases directed to the Biological Safety Officer or Quality Assurance Manager, together with a postage paid envelope for reply. After 6 weeks, those who had not replied were contacted again by post with a reminder. Data supplied on the completed forms were coded then input and sorted using Dataease database software.
RESULTS AND DISCUSSION
Of the 49 companies invited to submit details, 33 (67.3%) completed and returned the questionnaires. The 33 companies were undertaking work at one or more of three scales of operation, as follows:
-laboratory scale at 28 companies; -pilot plant scale at 11 companies; -production scale at seven companies.
Monitoring in the biotechnology industry {questions 1-14)
The first part of the questionnaire, in addition to establishing details of the scale of the work being done, asked whether the process micro-organisms being used were genetically modified and asked for details of the monitoring done, if any, for release of process micro-organisms. Monitoring was undertaken in 10 out of 28 laboratoryscale operations, nine out of 11 working at pilot scale and all seven working at production scale. This amounted to regular monitoring of the workplace being done at 14 of the 33 establishments that responded to the questionnnaire. Table 3 gives detail of the nature of the process organisms being used by the respondents at the time of receiving the questionnaire and the monitoring they undertook. Out of 24 who were using GMO, half monitored the workplace regularly. Of those that did not monitor, all but one were small-scale operations in University or Research Council laboratories. Seven of them commented that, because of the scale or infrequency of their work together with the laboratory containment and disinfection procedures in place, they did not consider monitoring the workplace to be necessary. The one company that used GMO at a larger scale than in the laboratory, but did not monitor for release, was handling modified strains of food yeast at pilot plant scale and stated that the reason they did not monitor was because the organism being used was not harmful to humans or the environment. Nine companies were not using genetically modified process organisms at the time the questionnaire was administered and two of these continued to monitor the workplace regularly. Five out of the 33 respondents regularly monitored outside as well as inside the workplace, four out of the five being those using GMO. None monitored solely outside. Table 4 summarizes the methods employed to undertake monitoring. The first three listed (swabs, contact plates and settle plates) may be considered qualitative, or at best semi-quantitative methods. Swabs comprise absorbent pads that are used to remove contaminants from surfaces for subsequent analysis. Contact plates are agar jelly plates pressed onto surfaces and onto which material, including live microbial contaminants, is adhered. These are then incubated to cultivate colonies. Settle plates are agar plates exposed to the atmosphere, onto which airborne particles settle by gravitation, and which then are incubated. The other sampling methods listed are more quantitative sampling methods, because they collect particles from a measured volume of air. The category 'microbiological air samplers' includes any method where material is collected from a measured volume of the workplace air and then is analysed for its microbiological content. Listed under separate categories are samples taken to measure total airborne particulate matter (for example, using electronic particle counters) and where monitoring is done by analysis of the product rather than by cultivation of micro-organisms. Microbiological analysis of air samples was the most likely method to be used, reflecting firstly the perception that the greatest risk of exposure to process microorganisms would be via inhalation, and secondly the need for biologically relevant information rather than data based, for example, on airborne particle counts. Out of 14 who gave details of the methods used, 11 used microbiological air samplers and all used them regularly. By comparison, settle plates were used to a similar extent on an infrequent basis but, despite being cheaper and easier to use, were less likely to be depended upon as part of a regular monitoring programme because of the nonquantitative nature of the results obtained. Table 5 lists the aerobiological samplers used to monitor in biotechnology. In almost all instances, the methods chosen were impaction samplers which collect the airborne particles directly onto agar media for cultivation. In only two recorded instances were samplers used, such as impingers collecting into liquid, where further sample preparation (dilution and spreading onto agar plates) would be needed after collection, despite this being the only one of those methods listed that could be run for a period greater than a few minutes to achieve a sample more representative of a full work shift. Most popular was the centrifugal impactor (RCS Biotest) which deposits airborne particles by centrifugal force from an impeller blade onto a plastic strip coated with agar media. With a small area for deposition of the airborne material (34 cm 2 ) and a sampling rate of 40 1. min 1 , the sampler can be run only for a short period, typically 0.58 min (Hering, 1989) , otherwise they would become overloaded and the sample would be uncountable. Similarly, the second most frequently used sampler, a single-stage sieve impactor (SAS sampler) operates at 90 1. min 1 to collect onto a 90 mm diameter plastic plate filled with agar media, which again limits the length of sampling time that can be used in all but sterile room conditions.
There are no commercially available personal samplers designed specifically for bioaerosol collection. Some personal aerosol sampling devices can be adapted to sample bioaerosols, for example, portable filtration devices used for gravimetric analysis can be used, although viable collection may be compromised by dehydration effects (Crook, 1995) . In our survey, portability and ease of use obviously was an important consideration, judging from the two most commonly used types of samplers both being battery-operated, integrated units with the possibility of being used as hand-held devices, compared to the more bulky and complicated researchoriented slit-to-agar and six-stage microbial impactors.
In addition to enquiring about the types of samplers used, the questionnaire asked for details of monitoring regimes. These are summarized in Table 6 . Most Table 5 . Aerobiological samplers used to monitor in biotechnology Q9: Type of aerobiological sampler used in monitoring Centrifugal impaction collector (RCS and RCS +; Biotest Ltd) = 7 Single-stage impaction collector (SAS; Cherwell^Labs Ltd) = 4 Slit-to-agar impaction collector (CaseJla Ltd) = 3 Six-stage impaction collector (Andersen Inc.) -2 Glass liquid impinger = 2 Slit-to-surface impactor (Burkard Ltd) = 1 Electronic partide counter -1 respondents (nine out of 14) had a formal programme, but the detail of that programme differed from one company to the next. The monitoring regimes were designed to accommodate the work schedule. For example, the three companies that monitored at least once a week were working at production scale, where the process was more likely to follow a predicted pattern from week to week. Where work was being done at a laboratory trial or pilot scale and where fermentations were run on a less regular basis, the frequency of monitoring was planned on an individual basis to coincide with the work.
Interpretation of results obtained from monitoring (questions 15-18)
Questions 15-18 were aimed to find out how the companies interpreted the results obtained from monitoring and how satisfied they were with the procedures available to them. Ten out of 14 companies that monitored the workplace on a regular basis expressed confidence in the procedures that they used. Those that were less confident highlighted a need for more sensitive assays, or accepted that the methods they used, such as settle plates, gave only limited information, but were used because of convenience.
On the whole, one of two approaches were adopted to interpret and use the results obtained from monitoring. The most common approach (cited by four respondents) was to compare sampling data obtained during process operation to a control or background value obtained when no process operation took place. A further two companies reported the use of a variation of this approach, by looking at trends in airborne microbial levels, set against pre-detennined alert and action levels. The other approach was to aim for the absence of process micro-organisms in the air during critical procedures, as reported by three companies. Two other companies took samples post-operation, using specific media to select for the presence of airborne process micro-organisms, with a pass level of an absence of process microorganism in the air. One company reported that they had simulated abnormal conditions as a positive control to obtain a measure of the airborne release of process micro-organisms in such a situation, while another company had identified likely emission points that they targetted for monitoring, the results of which they related to remedial action.
Actions taken as a consequence of monitoring mostly centred around modification of work procedures if process micro-organisms were detected in the air. This was reported by seven companies, while another used the data to set the frequency of monitoring, that is if a particular point in the process was identified as being more likely to result in release, appropriate containment was put in place and samples were taken with greater frequency. Individual examples of other procedures included the use of special advisory forms and a comment on the work ticket if a release was detected, inclusion of monitoring data in a monthly report, displaying the data in the fermentation hall and discussions of monitoring data at meetings with operational personnel. One company had established their own in-house standard for numbers of process micro-organisms in the air.
Further guidance, information and advice required {questions 19 and 20) In the final part of the questionnaire, the companies were asked what further guidance, information and advice they might require, in general and specifically from the HSE. A total of 17 companies, out of the 33 respondents, gave a range of replies, summarized in Table 7 .
The greatest need appeared to be for advice on what sampling methods to use and what strategies to adopt in the absence of any standard prescribed method for bioaerosol sampling. Three respondents suggested that they would welcome an exposure standard. However, since there is no epidemiological evidence of workrelated illness associated with exposure to process organisms it is not possible to set health-based standards at the present time. Other options might include setting a "benchmark" value based on what is considered to be good practice and achievable within the industry. Such an approach has been shown to be useful in the context of chemical exposures (Cocker et al., 1994) . CONCLUSION We have presented the results of a questionnaire administered to the biotechnology industry in which we explored their views on monitoring for release of process micro-organisms into the workplace and beyond. Although the total number of respondents to the questionnaire was fairly small, 33 in total, this was two-thirds of those to whom the questionnaire was sent. It is recognized that 60-75% represents a good response rate to postal questionnaires (Dillman, 1978) . Comparing the known details of those that did and did not reply suggested that the response was representative of the total. In turn, the 49 companies to whom the questionnaire was sent were, we felt, an adequate representation of the biotechnology industry in the U.K., being all those registered with HSE to handle genetically modified process organisms and therefore covering all those involved in working at what may be considered to be the more technically advanced end of the spectrum of biotechnology application.
The questionnaire highlighted a difference in approach to monitoring between companies involved in production, whether on a large scale or at pilot plant scale, and research work done at laboratory scale. All of those companies involved in production and most of those working at pilot scale monitored the level of process organisms in the workplace, whereas those working at laboratory scale were more likely to assume that good laboratory practice ensured no release of process organism.
There is an obligation on the company to assess risk of release and to employ effective containment for applications when GMO are used. However, there are few exposure standards for process products, none for process organisms and no recommended standard methods to monitor the workplace air in biotechnology. This means that each company has to design its own sampling strategy. Our questionnaire results showed that a range of monitoring methods and strategies were employed to provide information to be used to maintain or improve work conditions. What many companies felt they lacked was information on the typical levels of process micro-organisms that may expected to be airborne during normal workplace activity in biotechnology. Certainly, little data have been published but, as individual companies continue to monitor their workplace, they are developing an information base for their own work process of what concentrations of airborne micro-organisms are to be expected in association with certain stages in the fermentation process. However, it seems unlikely for commercial reasons that much of this information will be made available to other companies.
To address some of the information needs highlighted in the questionnaire, a report has been published describing sampling and assessment methods (Cottam and Crook, 1995) . This includes description of developments in analytical methods in microbiology, such as molecular biological techniques, which may in the future provide more rapid and sensitive assays required by the industry. To address the question of the typical levels of airborne biological material that may be expected to be found associated with biotechnology work, we have undertaken a study of a number of biotechnology sites to measure concentrations of viable airborne microorganisms and of endotoxins. This will be the subject of a later publication.
